Nexalin Technology Inc (NXL) - שווי שוק לרווח

The price trend on the GURU.Markets platform shown in this chart demonstrates the price action of Nexalin Technology, Inc. (NXL), which has a P/E ratio of -0.20. Nexalin Technology, Inc. (NXL) develops non-drug neurostimulation systems to combat anxiety using specialized currents. Expansion into the US and China is broadening the customer base, although limited insurance coverage is slowing growth. Meanwhile, stable demand for medical services is offset by logistics risks regarding components from Asia.

As a neurostimulation innovator, Nexalin Technology, Inc. (NXL) invests significant funds into R&D, which directly impacts net income and the calculated -0.20 coefficient. This metric measures the investment payback period via the ratio of market capitalization to earnings, allowing the business's current P/E to track whether cost inflation is offsetting the real efficiency of the company's technological leadership.